Creative Planning’s Sight Sciences SGHT Stock Holding History

Creative Planning’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,794	Closed	-$85.6K	–	4187
2025 Q4	$85.6K	Buy	+10,794	New	+$69K	﹤0.01%	3735

Other funds holding SGHT

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Creative Planning's SGHT Position: Q1 2026 in Review

Creative Planning sold out of Sight Sciences (SGHT) in Q1 2026, closing a stake of 10,794 shares — an estimated $85.6K sold.

Creative Planning first reported a position in SGHT in Q4 2025 and held it in 1 quarter. The position peaked at $85.6K in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

Creative Planning reported no remaining Sight Sciences position as of Q1 2026 after selling out during the quarter.
Creative Planning sold 10,794 Sight Sciences shares in Q1 2026, an estimated $85.6K.
Creative Planning first reported a position in Sight Sciences in Q4 2025 and held it in 1 quarter.
Creative Planning's Sight Sciences position peaked at $85.6K in Q4 2025.
114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.